Urea for treatment of acute SIADH in patients with subarachnoid hemorrhage: a single-center experience
Hyponatremia occurring as a result of the syndrome of inappropriate antidiuretic hormone secretion (SIADH) or cerebral salt wasting syndrome is a common complication in patients with subarachnoid hemorrhage (SAH). The efficacy and safety of urea as treatment for SIADH-induced hyponatremia has not been reported in this population.
This is a retrospective analysis of all patients admitted to our department for nontraumatic SAH between January 2003 and December 2008 (n = 368). All patients with SIADH-induced hyponatremia (plasma sodium < 135 mEq/L, urine sodium > 20 mEq/L, and osmolality > 200 mOsm/kg; absence of overt dehydration or hypovolemia; no peripheral edema or renal failure; no history of adrenal or thyroid disease) routinely received urea per os when hyponatremia was associated with clinical deterioration or remained less than 130 mEq/L despite saline solution administration.
Forty-two patients developed SIADH and were treated with urea. Urea was started after a median of 7 (IQR, 5–10) days and given orally at doses of 15–30 g tid or qid for a median of 5 (IQR, 3–7) days. The median plasma sodium increase over the first day of treatment was 3 (IQR, 1–6) mEq/L. Hyponatremia was corrected in all patients, with median times to Na+ >130 and >135 mEq/L of 1 (IQR, 1–2) and 3 (IQR, 2–4) days, respectively. Urea was well tolerated, and no adverse effects were reported.
Oral urea is an effective and well-tolerated treatment for SIADH-induced hyponatremia in SAH patients.
- Elhassan EA, Schrier RW: Hyponatremia: diagnosis, complications, and management including V2 receptor antagonists. Curr Opin Nephrol Hypertens 2011, 20:161–168. CrossRef
- Qureshi AI, Suri MF, Sung GY, Straw RN, Yahia AM, Saad M, Guterman LR, Hopkins LN: Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2002, 50:749–755. CrossRef
- Rabinstein AA, Bruder N: Management of hyponatremia and volume contraction. Neurocrit Care 2011, 15:354–360. CrossRef
- Mount DB: The brain in hyponatremia: both culprit and victim. Semin Nephrol 2009, 29:196–215. CrossRef
- Brimioulle S, Orellana-Jimenez C, Aminian A, Vincent JL: Hyponatremia in neurological patients: cerebral salt wasting versus inappropriate antidiuretic hormone secretion. Intensive Care Med 2008, 34:125–131. CrossRef
- Ellison DH, Berl T: Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 2007, 356:2064–2072. CrossRef
- Kao L, Al-Lawati Z, Vavao J, Steinberg GK, Katznelson L: Prevalence and clinical demographics of cerebral salt wasting in patients with aneurysmal subarachnoid hemorrhage. Pituitary 2009, 12:347–351. CrossRef
- Audibert G, Steinmann G, de Talancé N, Laurens MH, Dao P, Baumann A, Longrois D, Mertes PM: Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation. Anesth Analg 2009, 108:1922–1928. CrossRef
- Oh MS, Carroll HJ: Cerebral salt-wasting syndrome. We need better proof of its existence. Nephron 1999, 82:110–114. CrossRef
- Decaux G, Musch W, Soupart A: Management of hypotonic hyponatremia. Acta Clin Belg 2010, 65:437–445.
- Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN, Duldner JE Jr, Harbaugh RE, Patel AB, Rosenwasser RH: Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009, 40:994–1025. CrossRef
- Murphy T, Dhar R, Diringer M: Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit. Neurocrit Care 2009, 11:14–19. CrossRef
- Wright WL, Asbury WH, Gilmore JL, Samuels OB: Conivaptan for hyponatremia in the neurocritical care unit. Neurocrit Care 2009, 11:6–13. CrossRef
- Decaux G, Unger J, Brimioulle S, Mockel J: Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy. JAMA 1982, 247:471–474. CrossRef
- Decaux G, Andres C, Gankam KF, Soupart A: Treatment of euvolemic hyponatremia in the intensive care unit by urea. Crit Care 2010, 14:R184. CrossRef
- World Federation of Neurological Surgeons Committee: Report on a Universal Subarachnoid Hemorrhage Grading Scale. J Neurosurg 1988, 68:985–986.
- Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980, 6:1–9. CrossRef
- Samuels MA, Seifter JL: Encephalopathies caused by electrolyte disorders. Semin Neurol 2011, 31:135–138. CrossRef
- Hasan D, Wijdicks EF, Vermeulen M: Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol 1990, 27:106–108. CrossRef
- Wijdicks EF, Vermeulen M, Hijdra A, van Gijn J: Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful? Ann Neurol 1985, 17:137–140. CrossRef
- Sterns RH, Riggs JE, Schochet SS Jr: Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 1986, 314:1535–1542. CrossRef
- Soupart A, Schroeder B, Decaux G: Treatment of hyponatraemia by urea decreases risks of brain complications in rats. Brain osmolyte contents analysis. Nephrol Dial Transplant 2007, 22:1856–1863. CrossRef
- Aoyagi T, Engstrom GW, Evans WB, Summerskill WH: Gastrointestinal urease in man. I. Activity of mucosal urease. Gut 1966, 7:631–635. CrossRef
- Decaux G, Musch W: Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol 2008, 3:1175–1184. CrossRef
- Mayer SA, Solomon RA, Fink ME, Lennihan L, Stern L, Beckford A, Thomas CE, Klebanoff LM: Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage. Neurosurgery 1998, 42:759–767. CrossRef
- Suarez JI, Shannon L, Zaidat OO, Suri MF, Singh G, Lynch G, Selman WR: Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage. J Neurosurg 2004, 100:585–590. CrossRef
- Hasan D, Lindsay KW, Wijdicks EF, Murray GD, Brouwers PJ, Bakker WH, van Gijn J, Vermeulen M: Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. Stroke 1989, 20:1156–1161. CrossRef
- Mori T, Katayama Y, Kawamata T, Hirayama T: Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1999, 91:947–952. CrossRef
- Hantman D, Rossier B, Zohlman R, Schrier R: Rapid correction of hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. An alternative treatment to hypertonic saline. Ann Intern Med 1973, 78:870–875.
- Curtis NJ, van Heyningen C, Turner JJ: Irreversible nephrotoxicity from demeclocycline in the treatment of hyponatremia. Age Ageing 2002, 31:151–152. CrossRef
- Urea for treatment of acute SIADH in patients with subarachnoid hemorrhage: a single-center experience
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Annals of Intensive Care
- Online Date
- May 2012
- Online ISSN
- Additional Links
- Subarachnoid hemorrhage
- Author Affiliations
- 1. Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
- 3. Department of Intensive Care, Erasme University Hospital, Route de Lennik, 808, Brussels, B-1070, Belgium
- 2. Department of Internal Medicine, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium